2reverse splits
1-for-176 cumulative
+259.5%share growth, 1-year
XBRL EDGAR
16.0M → 1.9Bshares issued (XBRL history)
Quietfiling state
from EDGAR

Case Notes

Purple Biotech Ltd. has 2 reverse splits on record — cumulative 1-for-176. Its share count grew 259.5% over the last twelve months per XBRL EDGAR data.

No stress-language filings on record in our dataset. However, 1 supply registration (S-1/424B) appear in the last 12 months.

The current filing record is quiet: nothing newly registered, no recent stress flags. In our dataset, quiet is where every cycle began — the absence of filings is itself a data point, not a clearance. This record will be updated as new filings land on EDGAR.

Share Count Over Time

XBRL cover-page share counts from SEC EDGAR filings. Amber dashed lines mark reverse-split dates. 2 reverse splits on record.

Reverse Split Log

Each event consolidates shares — fewer shares, same market cap. Source: EDGAR corporate actions.

2024-09-171-for-18.2
2026-03-021-for-9.7

Cumulative effective ratio: 1-for-176— a share held at inception is now worth 1/176 of its original fraction.

424B Supply Pulse

Prospectus supplements (424B5) filed registering shares for resale — each bar is one month with a filing. Bars above average signal active distribution windows. Source: SEC EDGAR.

03 05 06 06 03 04 10 11 07 12 01 09
2020-032020-052020-062021-062022-032023-042023-102023-112024-072024-122025-012025-09

← Back to Registry